@Rameshkekunnaya Profile picture

Ramesh Kekunnaya

@Rameshkekunnaya

Pediatric Ophthalmologist #Childeyecare, Director, Child Sight Institute and Centre for Technology Innovation, LVPEI, Hyderabad Executive Member: #WSPOS

Joined September 2015
Similar User
LVPEI photo

@lvprasadeye

WSPOS photo

@WSPOS

Maneesh Bapaye photo

@drmaneeshbapaye

Anthony Vipin Das photo

@antonvipin

David Granet photo

@dgranet

Samrat Sarkar photo

@samratsar

Souvik Mandal photo

@souvikman1

Md Oliullah Abdal photo

@abdaloliullah

Aditi Desai photo

@aditi0212

Ramesh Kekunnaya Reposted

Savleen Kaur talks to Ramesh Kekunnaya and explores his paper titled "Visual outcomes and complications in infantile cataract surgery: a real-world scenario". Listen Here: youtu.be/1SCmyJt_f2Y Or search WSPOS on your preferred podcast platform.


Ramesh Kekunnaya Reposted

Did you manage to catch the last WSPOS Myopia Management IME session? Ramesh Kekunnaya (India) and Mark Bullimore (USA) moderated the session with valuable insights for real-world myopia management from a fantastic faculty. Watch Here: youtu.be/SHSXOVQhgrM

WSPOS's tweet image. Did you manage to catch the last WSPOS Myopia Management IME session?
Ramesh Kekunnaya (India) and Mark Bullimore (USA) moderated the session with valuable insights for real-world myopia management from a fantastic faculty.
Watch Here: <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/2BtxHvWFKN">youtu.be/SHSXOVQhgrM</a>

Ramesh Kekunnaya Reposted

Acquired esotropia: How important to get an MRI? @Rameshkekunnaya journals.healio.com/doi/10.3928/01…

JPOSJournal's tweet image. Acquired esotropia: How important to get an MRI? @Rameshkekunnaya <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/QPUJxgfBqz">journals.healio.com/doi/10.3928/01…</a>

Ramesh Kekunnaya Reposted

Acquired esotropia: clinical characteristics and surgical outcomes form the largest series @Rameshkekunnaya journals.healio.com/doi/10.3928/01…

JPOSJournal's tweet image. Acquired esotropia: clinical characteristics and surgical outcomes form the largest series @Rameshkekunnaya <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/QPUJxgfBqz">journals.healio.com/doi/10.3928/01…</a>

Myopia myopia and myopia. Please submit interesting papers!

We're calling for papers for a Topic Collection 👇 📣Slowing the Progression of Myopia📣 Reach a wide international audience through our open access publication model🌎 Find out more and submit your paper by 31st July 2023. 👇 bit.ly/3A5YW50

BMJ_Ophth's tweet image. We're calling for papers for a Topic Collection 👇 

📣Slowing the Progression of Myopia📣

Reach a wide international audience through our open access publication model🌎

Find out more and submit your paper by 31st July 2023. 👇
<a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/yrhTMz8I10">bit.ly/3A5YW50</a>


Ramesh Kekunnaya Reposted

We are honored to work in collaboration with the University of Hamburg on the below study. Link to the full article:scientificamerican.com/article/advers… #LVPEI #SoThatAllMaySee

lvprasadeye's tweet image. We are honored to work in collaboration with the University of Hamburg on the below study.

Link to the full article:<a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/ScvrxTHo96">scientificamerican.com/article/advers…</a>

#LVPEI #SoThatAllMaySee

Ramesh Kekunnaya Reposted

Ensuring access to safe environments, affordable health care, healthy food and appropriate education gives children the opportunity to develop and stay physically and mentally healthy. @Rameshkekunnaya @sciam scientificamerican.com/article/advers…


Ramesh Kekunnaya Reposted

@MindShiftKQED: Ensuring access to safe environments, affordable health care, healthy food and appropriate education gives children the opportunity to develop and stay physically and mentally healthy. @Rameshkekunnaya @sciam scientificamerican.com/article/advers…


Ramesh Kekunnaya Reposted

Continuing his support to the #innovations & #startupecosystem, @KTRBRS joins us as a Chief Guest at @LVPEIBioNEST's First #StartupChallenge. Join us in recognising the global best #eyecare innovations. @lvprasadeye, @BIRAC_2012, @DrManishDiwan, @rpallela, @visu_bio,@Rameshk

LVPEIBioNEST's tweet image. Continuing his support to the #innovations &amp; #startupecosystem, @KTRBRS joins us as a Chief Guest at @LVPEIBioNEST's First #StartupChallenge.  

Join us in recognising the global best #eyecare innovations.

@lvprasadeye, @BIRAC_2012, @DrManishDiwan, @rpallela, @visu_bio,@Rameshk

Ramesh Kekunnaya Reposted

#LVPEI has been ranked #8 among the world’s top global eye research institutions. Our commitment to advancing research in vision sciences & providing exceptional patient care has led to this achievement. #SCImago #GlobalRecognition #Research #SoThatAllMaySee #EyeHealth

lvprasadeye's tweet image. #LVPEI has been ranked #8 among the world’s top global eye research institutions. Our commitment to advancing research in vision sciences &amp; providing exceptional patient care has led to this achievement.

#SCImago #GlobalRecognition #Research #SoThatAllMaySee
#EyeHealth

Ramesh Kekunnaya Reposted

Our thanks to Dr Lekha Pandit, Director, Center for Advanced Neurological Research #NITTE for delivering 1st edition of endowment lecture on Management of Optic Nerve Inflammations in Children, initiated in honor of late Padma Shri Dr Kakarla Subba Rao #LVPEI #SoThatAllMaySee

lvprasadeye's tweet image. Our thanks to Dr Lekha Pandit, Director, Center for Advanced Neurological Research #NITTE for delivering 1st edition of endowment lecture on Management of Optic Nerve Inflammations in Children, initiated in honor of late Padma Shri Dr Kakarla Subba Rao
#LVPEI #SoThatAllMaySee
lvprasadeye's tweet image. Our thanks to Dr Lekha Pandit, Director, Center for Advanced Neurological Research #NITTE for delivering 1st edition of endowment lecture on Management of Optic Nerve Inflammations in Children, initiated in honor of late Padma Shri Dr Kakarla Subba Rao
#LVPEI #SoThatAllMaySee
lvprasadeye's tweet image. Our thanks to Dr Lekha Pandit, Director, Center for Advanced Neurological Research #NITTE for delivering 1st edition of endowment lecture on Management of Optic Nerve Inflammations in Children, initiated in honor of late Padma Shri Dr Kakarla Subba Rao
#LVPEI #SoThatAllMaySee
lvprasadeye's tweet image. Our thanks to Dr Lekha Pandit, Director, Center for Advanced Neurological Research #NITTE for delivering 1st edition of endowment lecture on Management of Optic Nerve Inflammations in Children, initiated in honor of late Padma Shri Dr Kakarla Subba Rao
#LVPEI #SoThatAllMaySee

Ramesh Kekunnaya Reposted

Calling all eye care domain innovators 📢 Are you ready to take your innovation to the next level? Join us and our impact partner @SocialAlphaIN at the #LVPEIStartupChallenge Apply here: lnkd.in/deFKT7P7 Learn more: lnkd.in/dsXxDK8G #OphthalmicStartups

LVPEIBioNEST's tweet image. Calling all eye care domain innovators 📢  

Are you ready to take your innovation to the next level? Join us and our impact partner @SocialAlphaIN   at the #LVPEIStartupChallenge 

Apply here: <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/wOp5xIfhc0">lnkd.in/deFKT7P7</a>

Learn more: <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/TRb0dPoIpt">lnkd.in/dsXxDK8G</a>

 #OphthalmicStartups

Ramesh Kekunnaya Reposted

Applications now open for the first LVPEI Startup Challenge 2023! A platform for startups to engage with clinical KOLs, investors and industry and be recognized as the best #Eyecare start-up globally!! Apply here: forms.gle/sj9hhxaxbWpa1c… #challenge #pitch #incubation #startup

LVPEIBioNEST's tweet image. Applications now open for the first LVPEI Startup Challenge 2023!

A platform for startups to engage with clinical KOLs, investors and industry and be recognized as the best #Eyecare start-up globally!!

Apply here: <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/D6GK4IZP0R">forms.gle/sj9hhxaxbWpa1c…</a>

 #challenge #pitch #incubation #startup

Applications are now open for the first LVPEI Startup Challenge 2023! A platform for startups to engage with clinical KOLs, investors, and industry and be recognized as the best #Eyecare start-up globally!! Apply here: lnkd.in/deFKT7P7

Rameshkekunnaya's tweet image. Applications are now open for the first LVPEI Startup Challenge 2023!

A platform for startups to engage with clinical KOLs, investors, and industry and be recognized as the best #Eyecare start-up globally!!
Apply here: <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/rHl5VdNHGo">lnkd.in/deFKT7P7</a>

Ramesh Kekunnaya Reposted

WSPOS IME - Comprehensive Update on Myopia Management - Recording available for registered participants. If you registered for last month's IME Myopia Symposia, check your email to access the recordings. *You should have received an email from programme@wspos.org with the links!

WSPOS's tweet image. WSPOS IME - Comprehensive Update on Myopia Management - Recording available for registered participants.
If you registered for last month's IME Myopia Symposia, check your email to access the recordings.
*You should have received an email from programme@wspos.org with the links!

Ramesh Kekunnaya Reposted

Celebrating 🎊 5th Anniversary of #LVPEI Natco Eye Centre in Kothur, Rangareddy District #Telangana. It has been a privilege 🙌 to touch and impact so many lives along the way. #GratitudeToDonor 🙏 @pharma_natco #SoThatAllMaySee #CommunityEyeCare #RuralEyeCare #SecondaryCentre

lvprasadeye's tweet image. Celebrating 🎊 5th Anniversary of #LVPEI Natco Eye Centre in Kothur, Rangareddy District #Telangana. 
It has been a privilege 🙌 to touch and impact so many lives along the way. #GratitudeToDonor 🙏 @pharma_natco
#SoThatAllMaySee #CommunityEyeCare #RuralEyeCare #SecondaryCentre

Ramesh Kekunnaya Reposted

Children’s Eye Care Week was successfully concluded with the #AwareneasWalk on 20 Nov across #LVPEI’s Hyderabad, Bhubaneswar, Visakhapatnam & Vijayawada Campuses, theme – Let’s Combat Myopia!  Other activities included awareness talk, screening programs & drawing competitions.

lvprasadeye's tweet image. Children’s Eye Care Week was successfully concluded with the #AwareneasWalk on 20 Nov across #LVPEI’s Hyderabad, Bhubaneswar, Visakhapatnam &amp; Vijayawada Campuses, theme – Let’s Combat Myopia! 

Other activities included awareness talk, screening programs &amp; drawing competitions.
lvprasadeye's tweet image. Children’s Eye Care Week was successfully concluded with the #AwareneasWalk on 20 Nov across #LVPEI’s Hyderabad, Bhubaneswar, Visakhapatnam &amp; Vijayawada Campuses, theme – Let’s Combat Myopia! 

Other activities included awareness talk, screening programs &amp; drawing competitions.
lvprasadeye's tweet image. Children’s Eye Care Week was successfully concluded with the #AwareneasWalk on 20 Nov across #LVPEI’s Hyderabad, Bhubaneswar, Visakhapatnam &amp; Vijayawada Campuses, theme – Let’s Combat Myopia! 

Other activities included awareness talk, screening programs &amp; drawing competitions.
lvprasadeye's tweet image. Children’s Eye Care Week was successfully concluded with the #AwareneasWalk on 20 Nov across #LVPEI’s Hyderabad, Bhubaneswar, Visakhapatnam &amp; Vijayawada Campuses, theme – Let’s Combat Myopia! 

Other activities included awareness talk, screening programs &amp; drawing competitions.

Ramesh Kekunnaya Reposted

Today is #WorldPrematurityDay. Globally, more than 1 in 10 of all babies are born preterm - before 37 weeks of pregnancy. Babies #BornTooSoon deserve every chance to live, 💕 and thrive. More: bit.ly/3CpTJDO


Would you like to hear more about the real-world data on the benefits of atropine treatment? Tune into this weekend's IME Event to listen to discussions on this and much more! Register: ow.ly/uBRs50LoAkB *This event is FREE to attend. *Time zones: ow.ly/J4aW50LoAkC

WSPOS's tweet image. Would you like to hear more about the real-world data on the benefits of atropine treatment? Tune into this weekend's IME Event to listen to discussions on this and much more!
Register: <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/BWxPHFB8Dl">ow.ly/uBRs50LoAkB</a> 
*This event is FREE to attend. 
*Time zones: <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/FmHf2EnLLt">ow.ly/J4aW50LoAkC</a>
WSPOS's tweet image. Would you like to hear more about the real-world data on the benefits of atropine treatment? Tune into this weekend's IME Event to listen to discussions on this and much more!
Register: <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/BWxPHFB8Dl">ow.ly/uBRs50LoAkB</a> 
*This event is FREE to attend. 
*Time zones: <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/FmHf2EnLLt">ow.ly/J4aW50LoAkC</a>


Ramesh Kekunnaya Reposted

Would you like to hear more about the real-world data on the benefits of atropine treatment? Tune into this weekend's IME Event to listen to discussions on this and much more! Register: ow.ly/uBRs50LoAkB *This event is FREE to attend. *Time zones: ow.ly/J4aW50LoAkC

WSPOS's tweet image. Would you like to hear more about the real-world data on the benefits of atropine treatment? Tune into this weekend's IME Event to listen to discussions on this and much more!
Register: <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/BWxPHFB8Dl">ow.ly/uBRs50LoAkB</a> 
*This event is FREE to attend. 
*Time zones: <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/FmHf2EnLLt">ow.ly/J4aW50LoAkC</a>
WSPOS's tweet image. Would you like to hear more about the real-world data on the benefits of atropine treatment? Tune into this weekend's IME Event to listen to discussions on this and much more!
Register: <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/BWxPHFB8Dl">ow.ly/uBRs50LoAkB</a> 
*This event is FREE to attend. 
*Time zones: <a style="text-decoration: none;" rel="nofollow" target="_blank" href="https://t.co/FmHf2EnLLt">ow.ly/J4aW50LoAkC</a>

Loading...

Something went wrong.


Something went wrong.